Ocytocin,
Oxytocin,
Pitocin,
Syntocinon,
OXYTOCIN,
Pitocin,
50-56-6,
Ocytocin,
Endopituitrina,
Orasthin,
Syntocinon,
Oxitocina,
Oxytocine,
Oxytocinum,
Oxytocic hormone,
(1-Hemicystine)oxytocin,
Piton S,
3-Isoleucine-8-leucine vasopressin,
UNII-1JQS135EYN,
Oxystin,
Partocon,
alpha-Hypophamine,
Synthetic oxytocin,
1JQS135EYN,
Ocytocinum,
Syntocinone,
Oxtocin,
Presoxin,
Synpitan,
Syntocin,
Utedrin,
Uteracon,
Di-sipidin,
CHEBI:7872,
CHEMBL395429,
Nobitocin S,
Atonin O,
Oxetakain [Czech],
Ossitocina [DCIT],
MFCD00076731,
Oxytocine [INN-French],
Oxytocinum [INN-Latin],
Oxitocina [INN-Spanish],
Posterior pituitary extract,
OXT,
HSDB 2182,
Ossitocina,
Oxetakain,
Oxoject,
EINECS 200-048-4,
Oxytocin (Syntocinon),
BRN 3586108,
[3H]oxytocin,
1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide,
L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide,
Vasopressin, 3-L-isoleucine-8-L-leucine-,
OXYTOCIN 5 USP UNITS IN DEXTROSE 5%,
OXYTOCIN 10 USP UNITS IN DEXTROSE 5%,
OXYTOCIN 20 USP UNITS IN DEXTROSE 5%,
[3H]OT (human, mouse, rat),
Oxytocin [USP:INN:BAN:JAN],
Syntocinon (TN),
Oxytocin (TN),
Oxytocin,(S),
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide,
L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1-6)-disulfide,
C43H66N12O12S2,
Pitocin (TN),
SCHEMBL29048,
Oxytocin (JP17/USP/INN),
GTPL2174,
GTPL2176,
DTXSID8048361,
BCBcMAP01_000094,
XNOPRXBHLZRZKH-DSZYJQQASA-N,
A-HYPOPHAMINEOXYTOCICHORMONE,
AC1L9735,
BDBM50205990,
TI-001,
AKOS015994657,
HS-2021,
NCGC00167132-01,
AC-28730,
AB0007936,
FT-0658171,
6369-EP2272841A1,
6369-EP2292621A1,
6369-EP2301936A1,
6369-EP2308479A2,
6369-EP2311811A1,
C00746,
D00089,
076O731,
SR-01000945111,
SR-01000945111-1,
W-105951,
Oxytocin, European Pharmacopoeia (EP) Reference Standard,
Oxytocin, United States Pharmacopeia (USP) Reference Standard,
Oxytocin, lyophilized powder, ~15 IU/mg solid (Prepared from synthetic oxytocin),
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide,
(S)-N-((S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((S)-sec-butyl)-16-(4-hydrox,
L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1-->6)-disulfide,
Otx,
ybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide,
Oxytocin acetate,
perlacton,
|A-Hypophamine,
Oxytocin-,
D0M3FJ,
D0T6FH,
Oxytocin [USAN:BAN:INN:JAN],
Oxytocin [USAN:INN:BAN:JAN],
CID439302,
C43-H66-N12-O12-S2,
Oxytocin (intranasal/ muco system, autism),
B4723,
D010121,
OT,
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, cyclic 1-6 disulfide,
34330-23-9,